Heart rate: the escalation transient This is the two-instruments effect covered above: a modest chronic mean, a larger escalation peak, and a lean, East-Asian tail. Blood pressure moves the other way, down about 6 to 9 mmHg systolic, so the heart-rate rise is not a blood-pressure effect, and it reverses when the drug stops. Low blood sugar tracks the insulin background On its own tirzepatide is insulin-sparing and rarely causes low blood sugar
Izzo JG, Malhotra U, Wu TT, Ensor J, Luthra R, Lee JH, Swisher SG , Liao Z, Chao KS, Hittelman WN, Aggarwal BB, Ajani JA
ISRN Endocrinology
Other questions also warrant further research, such as understanding why some patients with OSA dont fully respond to GLP-1 treatments
(a) Schematic representation of the AtNUDX23 and AtNUDX23-E169Q proteins used in this study